Compare BBBY & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBBY | GEVO |
|---|---|---|
| Founded | 1971 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 573.5M | 470.1M |
| IPO Year | N/A | 2011 |
| Metric | BBBY | GEVO |
|---|---|---|
| Price | $6.98 | $1.96 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $8.00 | $6.42 |
| AVG Volume (30 Days) | 2.0M | ★ 2.6M |
| Earning Date | 02-23-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,074,337,000.00 | $120,932,000.00 |
| Revenue This Year | N/A | $913.54 |
| Revenue Next Year | $5.03 | $11.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 675.75 |
| 52 Week Low | $3.54 | $0.92 |
| 52 Week High | $12.65 | $2.95 |
| Indicator | BBBY | GEVO |
|---|---|---|
| Relative Strength Index (RSI) | 59.76 | 40.65 |
| Support Level | $6.43 | $1.94 |
| Resistance Level | $7.40 | $2.12 |
| Average True Range (ATR) | 0.44 | 0.08 |
| MACD | 0.14 | -0.00 |
| Stochastic Oscillator | 78.96 | 13.16 |
Bed Bath & Beyond Inc is an ecommerce-focused retailer with an affinity model that owns or has ownership interests in various retail brands, offering a comprehensive array of products and services that enable its customers to enhance everyday life through quality, style, and value. The Company currently owns Bed Bath & Beyond, Overstock, buybuy BABY, and other related brands and websites as well as a blockchain asset portfolio.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.